Hikma Pharmaceuticals (LON:HIK) Price Target Raised to GBX 1,870

Posted by Brenda Bartman on Aug 15th, 2026

Hikma Pharmaceuticals (LON:HIK – Free Report) had its target price lifted by Citigroup from GBX 1,700 to GBX 1,870 in a research report report published on Wednesday morning,Digital Look reports. The brokerage currently has a buy rating on the stock.

Other equities analysts also recently issued research reports about the company. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a GBX 1,950 price objective on shares of Hikma Pharmaceuticals in a research report on Friday, August 7th. Berenberg Bank upped their target price on shares of Hikma Pharmaceuticals from GBX 1,800 to GBX 2,100 and gave the stock a “buy” rating in a research report on Tuesday. Finally, Jefferies Financial Group upped their target price on shares of Hikma Pharmaceuticals from GBX 1,850 to GBX 1,870 and gave the stock a “buy” rating in a research report on Tuesday, May 5th. Six research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of GBX 2,060.

Check Out Our Latest Report on HIK

Hikma Pharmaceuticals Trading Down 0.2%

LON HIK opened at GBX 1,640 on Wednesday. The company has a quick ratio of 1.27, a current ratio of 1.98 and a debt-to-equity ratio of 77.57. Hikma Pharmaceuticals has a twelve month low of GBX 1,187 and a twelve month high of GBX 1,865. The firm has a market capitalization of £3.43 billion, a PE ratio of 9.06, a P/E/G ratio of 2.38 and a beta of 0.66. The stock’s 50 day moving average is GBX 1,554.45 and its 200 day moving average is GBX 1,456.86.

Insider Activity at Hikma Pharmaceuticals

In related news, insider Tobias Hestler purchased 7,500 shares of the company’s stock in a transaction dated Monday, August 10th. The shares were purchased at an average cost of GBX 1,648 per share, with a total value of £123,600. 22.04% of the stock is currently owned by corporate insiders.

About Hikma Pharmaceuticals

(Get Free Report)

At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly. We are a trusted, reliable partner and dependable source of over 820+ (as of Feb 2026) high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe.